Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wee Loong Chin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|January 9, 2025
SampleExplorer: using language models to discover relevant transcriptome dataWee Loong Chin, Timo Lassmann
Lung Cancer (Amsterdam, Netherlands)|November 25, 2021
Immune checkpoint inhibitor therapy for malignant pleural mesotheliomaAnna K Nowak, Wee Loong Chin, Synat Keam, et al.
Current Opinion in Pulmonary Medicine|April 15, 2026
Update on pleural mesotheliomaDeshawn Chong Xuan Tan, Wee Loong Chin, Yun Chor Gary Lee
Journal of Molecular Biology|March 30, 2010
Characterising the binding specificities of the subunits associated with the KMT2/Set1 histone lysine methyltransferaseBen L Murton, Wee Loong Chin, Chris P Ponting, et al.
Frontiers in Immunology|March 6, 2020
Sensitizing the Tumor Microenvironment to Immune Checkpoint TherapyRachael M Zemek, Wee Loong Chin, Anna K Nowak, et al.
Iscience|October 30, 2024
Mesothelioma survival prediction based on a six-gene transcriptomic signatureKiarash Behrouzfar, Steve E Mutsaers, Wee Loong Chin, et al.
Lung Cancer (Amsterdam, Netherlands)|January 6, 2020
A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesotheliomaWei-Sen Lam, Jenette Creaney, Fred K Chen, et al.
Frontiers in Immunology|May 31, 2022
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive CombinationsNicola Principe, Wayne J Aston, Danika E Hope, et al.
Scientific Data|May 3, 2024
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapyWee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, et al.
Nature Communications|August 19, 2022
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in miceRachael M Zemek, Wee Loong Chin, Vanessa S Fear, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|January 9, 2025
SampleExplorer: using language models to discover relevant transcriptome dataWee Loong Chin, Timo Lassmann
Lung Cancer (Amsterdam, Netherlands)|November 25, 2021
Immune checkpoint inhibitor therapy for malignant pleural mesotheliomaAnna K Nowak, Wee Loong Chin, Synat Keam, et al.
Current Opinion in Pulmonary Medicine|April 15, 2026
Update on pleural mesotheliomaDeshawn Chong Xuan Tan, Wee Loong Chin, Yun Chor Gary Lee
Journal of Molecular Biology|March 30, 2010
Characterising the binding specificities of the subunits associated with the KMT2/Set1 histone lysine methyltransferaseBen L Murton, Wee Loong Chin, Chris P Ponting, et al.
Frontiers in Immunology|March 6, 2020
Sensitizing the Tumor Microenvironment to Immune Checkpoint TherapyRachael M Zemek, Wee Loong Chin, Anna K Nowak, et al.
Iscience|October 30, 2024
Mesothelioma survival prediction based on a six-gene transcriptomic signatureKiarash Behrouzfar, Steve E Mutsaers, Wee Loong Chin, et al.
Lung Cancer (Amsterdam, Netherlands)|January 6, 2020
A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesotheliomaWei-Sen Lam, Jenette Creaney, Fred K Chen, et al.
Frontiers in Immunology|May 31, 2022
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive CombinationsNicola Principe, Wayne J Aston, Danika E Hope, et al.
Scientific Data|May 3, 2024
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapyWee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, et al.
Nature Communications|August 19, 2022
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in miceRachael M Zemek, Wee Loong Chin, Vanessa S Fear, et al.
Pageof 2